Industry News | tctmd.com

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Industry News

Device to Sand Away Severe Calcium in Coronary Arteries Shows Long-Term Positive Results in a Difficult-to-Treat Patient Population

May 07, 2015

News Industry News

Medtronic to Unveil First-of-Its-Kind Clinical Data for Cardiac Therapies at Heart Rhythm 2015

May 06, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Industry News

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

News Industry News

Symic Biomedical Selects Vascular Clinical Candidate

July 20, 2015

News Industry News

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

July 20, 2015

News Industry News

Biotronik launches CRT in women study

July 08, 2015

News Industry News

UH Case Medical Center first in Ohio to implant new ventricular assist device

June 04, 2015

Subscribe to Industry News

Advertisement

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

Device to Sand Away Severe Calcium in Coronary Arteries Shows Long-Term Positive Results in a Difficult-to-Treat Patient Population

Medtronic to Unveil First-of-Its-Kind Clinical Data for Cardiac Therapies at Heart Rhythm 2015

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

Symic Biomedical Selects Vascular Clinical Candidate

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

Biotronik launches CRT in women study

UH Case Medical Center first in Ohio to implant new ventricular assist device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content